{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:31:26Z","timestamp":1722573086539},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T00:00:00Z","timestamp":1408060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s11046-014-9799-4","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T02:34:53Z","timestamp":1407983693000},"page":"197-206","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Killing Rates for Caspofungin Against Candida albicans After Brief and Continuous Caspofungin Exposure in the Presence and Absence of Serum"],"prefix":"10.1007","volume":"178","author":[{"given":"Ren\u00e1t\u00f3","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Gesztelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Kardos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Dom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ka","family":"Ber\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Majoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"9799_CR1","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/AAC.01584-09","volume":"54","author":"D Andes","year":"2010","unstructured":"Andes D, Diekema DJ, Pfaller MA, Bohrmuller J, Marchillo K, Lepak A. In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrob Agents Chemother. 2010;54:2497\u2013506.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1128\/AAC.00291-06","volume":"50","author":"CJ Clancy","year":"2006","unstructured":"Clancy CJ, Huang H, Cheng S, Derendorf H, Nguyen MH. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob Agents Chemother. 2006;50:2569\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijantimicag.2009.09.003","volume":"35","author":"KT Nguyen","year":"2010","unstructured":"Nguyen KT, Ta P, Hoang BT, Cheng S, Hao B, Nguyen MH, et al. Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates. Int J Antimicrob Agents. 2010;35:80\u20134.","journal-title":"Int J Antimicrob Agents"},{"key":"9799_CR4","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1128\/AAC.01480-08","volume":"53","author":"KT Nguyen","year":"2009","unstructured":"Nguyen KT, Ta P, Hoang BT, Cheng S, Hao B, Nguyen MH, et al. Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis and C. krusei isolates. Antimicrob Agents Chemother. 2009;53:3347\u201352.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR5","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/AAC.00999-10","volume":"55","author":"RK Shields","year":"2011","unstructured":"Shields RK, Nguyen MH, Du C, Press E, Cheng S, Clancy CJ. Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways, but eliminated in human serum. Antimicrob Agents Chemother. 2011;55:2641\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1099\/jmm.0.066381-0","volume":"63","author":"R Kov\u00e1cs","year":"2014","unstructured":"Kov\u00e1cs R, Gesztelyi R, Ber\u00e9nyi R, Dom\u00e1n M, Kardos G, Juh\u00e1sz B, et al. Killing rates exerted by caspofungin in 50% serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua. J Med Microbiol. 2014;63:186\u201394.","journal-title":"J Med Microbiol"},{"key":"9799_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11046-012-9554-7","volume":"174","author":"R F\u00f6ldi","year":"2012","unstructured":"F\u00f6ldi R, Kov\u00e1cs R, Gesztelyi R, Kardos G, Ber\u00e9nyi R, Juh\u00e1sz B, et al. Comparison of in vitro and in vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans. Mycopathol. 2012;174:311\u20138.","journal-title":"Mycopathol"},{"key":"9799_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12281-013-0136-z","volume":"7","author":"A Nasar","year":"2013","unstructured":"Nasar A, Ryan L, Frei CR, Cota JM, Wiederhold NP. Influence of serum and albumin on echinocandin in vitro potency and pharmacodynamics. Curr Fungal Infect Rep. 2013;7:89\u201395.","journal-title":"Curr Fungal Infect Rep"},{"key":"9799_CR9","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/JCM.02350-07","volume":"46","author":"Z Szab\u00f3","year":"2008","unstructured":"Szab\u00f3 Z, T\u00f3th B, Kov\u00e1cs M, Kardos G, Mar\u00e1z A, Rozgonyi F, et al. Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification. J Clin Microbiol. 2008;46:1824\u20135.","journal-title":"J Clin Microbiol"},{"key":"9799_CR10","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 3rd ed. M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA (2008)."},{"key":"9799_CR11","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1128\/AAC.05134-11","volume":"55","author":"OA Cornely","year":"2011","unstructured":"Cornely OA, Vehreschild JJ, Vehreschild MJ, W\u00fcrthwein G, Arenz D, Schwartz S, et al. Phase II dose escalation study of caspofungin for invasive Aspergillosis. Antimicrob Agents Chemother. 2011;55:5798\u2013803.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR12","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/AAC.00160-09","volume":"53","author":"E Cant\u00f3n","year":"2009","unstructured":"Cant\u00f3n E, Pem\u00e1n J, Valentin A, Espinel-Ingroff A, Gobernado M. In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies. Antimicrob Agents Chemother. 2009;53:3108\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","volume":"14","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14:164\u201376.","journal-title":"Drug Resist Updat."},{"key":"9799_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/AAC.01486-12","volume":"57","author":"LA Walker","year":"2013","unstructured":"Walker LA, Gow NA, Munro CA. Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob Agents Chemother. 2013;57:146\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"9799_CR15","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1128\/AAC.49.12.5058-5068.2005","volume":"49","author":"A Louie","year":"2005","unstructured":"Louie A, Deziel M, Liu W, Drusano MF, Gumbo T, Drusano GL. Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity. Antimicrob Agents Chemother. 2005;49:5058\u201368.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9799-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-014-9799-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9799-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:45:54Z","timestamp":1559346354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-014-9799-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":15,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["9799"],"URL":"https:\/\/doi.org\/10.1007\/s11046-014-9799-4","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]}}}